Abstract:Background: T cell epitope prediction methods have been broadly utilized to facilitate epitope discovery in infectious agents and help design reagents, diagnostics, and vaccines. Current prediction methods are mainly focused on peptide presentation by MHC molecules, which is a necessary but not sufficient requirement for an epitope. For complex pathogens such as bacteria, it would be desirable to make such predictions more specific to limit the number of candidates that have to be experimentally tested. Objective: To develop a machine learning-based prediction model that integrates both peptide-level and antigen-level features to improve the specificity of CD4+ T cell epitope predictions for bacteria. Methods: We used a dataset of 20,216 peptides from Mycobacterium tuberculosis (Mtb), tested for T cell recognition in Mtb-infected participants, that led to the discovery of n = 144 peptide epitopes. For each peptide, we calculated six peptide-level features (e.g. MHC class II binding predictions and conservation scores) and six antigen-level features (e.g. including RNA expression levels and subcellular localization scores). Three machine learning algorithms: Random Forest, Gradient Boosting, and XGBoost were trained using stratified, 5-fold cross-validation and combined into an ensemble model. Experimental validation was performed on Streptococcus pneumoniae peptides, using ex vivo IFNγ assays to confirm the predictive performance. Results: The ensemble model achieved an ROC-AUC of 0.91 in predicting immunogenic peptides in the Mycobacterium tuberculosis (Mtb) dataset. Gene expression and conservation were identified as the most impactful features, followed by MHC class II binding predictions. When validated on an independent Bordetella pertussis dataset, the model demonstrated accurate predictive capability, especially for peptides with broad recognition in the participant cohort (ROC-AUC up to 0.82). Prospectively applying the model to Streptococcus pneumoniae, we synthesized peptides predicted by our ensemble model to be immunogenic or non-immunogenic. Ex vivo testing with PBMCs from healthy participants showed that peptides predicted to be immunogenic elicited significantly higher IFNγ responses than non-immunogenic peptides, validating the model. Conclusions: Our machine learning approach, integrating both peptide and antigen features, effectively predicts immunogenic CD4+ T cell epitopes across different bacterial pathogens. This method enhances epitope selection efficiency, aiding vaccine development and immunological research by reducing the need for extensive experimental screening.

Integrated, high-dimensional analysis of CD4 T cell epitope specificities and phenotypes reveals unexpected diversity in the response to Mycobacterium tuberculosis

Induction of an Immune-Protective T-Cell Repertoire with Diverse Genetic Coverage by a Novel Viral-Vectored Tuberculosis Vaccine in Humans

Identification of differentially recognized T cell epitopes in the spectrum of tuberculosis infection

Limited T cell receptor beta variable repertoire responses to ESAT-6 and CFP-10 in subjects infected with Mycobacterium tuberculosis

T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection

Human Cd8(+) T Cells From Tb Pleurisy Respond To Four Immunodominant Epitopes In Mtb Cfp10 Restricted By Hla-B Alleles

Computational analysis of epitope-specific T-cell repertoires.

Evidence for Highly Variable, Region-Specific Patterns of T-Cell Epitope Mutations Accumulating in Mycobacterium tuberculosis Strains

De novo identification of CD4 + T cell epitopes

High-throughput and high-dimensional single-cell analysis of antigen-specific CD8+ T cells

Dr*W201/P65 Tetramer Visualization Of Epitope-Specific Cd4 T-Cell During M. Tuberculosis Infection And Its Resting Memory Pool After Bcg Vaccination

CD4+ T cell epitope identification de novo

In Silico Identification of Cytotoxic T Lymphocyte Epitopes Encoded by RD5 Region of Mycobacterium Tuberculosis.

Therapy modulates the response to T cell epitopes over the spectrum of tuberculosis infection

Identification of Novel Cytotoxic T Lymphocyte Epitopes of Drug- Resistance Related Protein InhA from Mycobacterium tuberculosis

A mass cytometry approach to track the evolution of T cell responses during infection and immunotherapy by paired T cell receptor repertoire and T cell differentiation state analysis

From Antigens to Immune Responses: Shaping the Future of TB Detection and Prevention

Scalable and comprehensive characterization of antigen-specific CD8 T cells using multi-omics single cell analysis

Use of HLA-DR08032/E7 and HLA-DR0818/E7 tetramers in tracking of epitope-specific CD4+ T cells in active and convalescent tuberculosis patients compared with control donors

High-throughput analysis of T cell-monocyte interaction in human tuberculosis

Predicting Immunogenic CD4+ T Cell Epitopes in Bacteria Using Antigen and Peptide Features